By investigating LR interactions involving immunomodulatory targets (CRI-iAtlas), we identified interactions between CD274 (PD-L1), its receptor PDCD1 (PD-1) and its costimulator CD80 (B7-1) exclusively in RP-like tumours (figure 4F). Here, CD80 is linked to neoplasm.